Astrid‐Helene Ravn Jørgensen

Astrid‐Helene Ravn Jørgensen

Auto-generated profile, based on publicly available information

Astrid‐Helene Ravn Jørgensen

Department of Dermato‐Venereology & Wound Healing Centre Bispebjerg Hospital Copenhagen Denmark

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2019 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
YYYiqiu Yao
Yiqiu Yao
AJAstrid‐Helene Ravn Jørgensen
Astrid‐Helene Ravn Jørgensen
STSimon Francis Thomsen
Simon Francis Thomsen

13 September 2019 in Experimental Dermatology
Verified
Journal Article
Open access
PDF file
AJAstrid‐Helene Ravn Jørgensen
Astrid‐Helene Ravn Jørgensen
STSimon Francis Thomsen
Simon Francis Thomsen
KKKatrine Elisabeth Karmisholt
Katrine Elisabeth Karmisholt
HRHans Christian Ring
Hans Christian Ring
Hidradenitis suppurativa (HS) tunnels and Crohn's disease (CD) fistulas are a challenge to treat. Although pathogenic similarities have been described between HS and CD, recent studies indicate that clinical, microbiological, immunological and imaging characteristics differ between these diseases. This review highlights the differences between HS tunnels and CD fistulas. Next‐generation sequencing studies demonstrate a microbiome in HS tunnels dominated by Porphyromonas spp., Prevotella spp. whereas no specific bacteria have been associated with cutaneous CD. Immunologically, TNF has been found upregulated in HS tunnels along with various interleukins (IL‐8, IL‐16, IL‐1α and IL‐1β). In CD fistulas, Th1, Th17, IL‐17, IFN‐ɤ, TNF and IL‐23 are increased. US imaging is an important tool in HS. US of HS tunnels depict hypoechoic band‐like structure across skin layers in the dermis and/or hypodermis connected to the base of a widened hair follicle. In CD, MR imaging of simple perianal fistulas illustrates a linear, non‐branching inflammatory tract relating to an internal opening in the anus or low rectum and an external opening to the skin surface. An increased awareness of the immediate potential differences between HS tunnels and CD fistulas may optimize treatment regimens of these intractable skin manifestations.

17 December 2019 in Archives of Dermatological Research
Verified
Journal Article
Closed access
PDF file
AJAstrid-Helene Ravn Jørgensen
Astrid-Helene Ravn Jørgensen
JHJesper Grønlund Holm
Jesper Grønlund Holm
MGMisbah Noshela Ghazanfar
Misbah Noshela Ghazanfar
YYYiqiu Yao
Yiqiu Yao
HRHans Christian Ring
Hans Christian Ring
STSimon Francis Thomsen
Simon Francis Thomsen

4 March 2021 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
AJAstrid‐Helene Ravn Jørgensen
Astrid‐Helene Ravn Jørgensen
YYYiqiu Yao
Yiqiu Yao
STSimon Francis Thomsen
Simon Francis Thomsen
HRHans Christian Ring
Hans Christian Ring

23 August 2019 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
AJAstrid‐Helene Ravn Jørgensen
Astrid‐Helene Ravn Jørgensen
YYYiqiu Yao
Yiqiu Yao
MGMisbah Noshela Ghazanfar
Misbah Noshela Ghazanfar
HRHans Christian Ring
Hans Christian Ring
STSimon Francis Thomsen
Simon Francis Thomsen

1 July 2020 in JAMA Dermatology
Verified
Journal Article
Open access
PDF file
AJAstrid-Helene Ravn Jørgensen
Astrid-Helene Ravn Jørgensen
JAJulie Aarestrup
Julie Aarestrup
JBJennifer L. Baker
Jennifer L. Baker
STSimon Francis Thomsen
Simon Francis Thomsen
Hidradenitis suppurativa (HS) is a painful, chronic inflammatory skin disease associated with substantial individual morbidity and costs to the health care system.1-7 Hidradenitis suppurativa has an estimated global prevalence of 1% to 4%,6 but the true prevalence is likely higher, because HS represents an underdiagnosed condition.